Harwood Feffer LLP Announces Investigation of Galena Biopharma, Inc.

NEW YORK, Feb. 14, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against Galena Biopharma, Inc. ("Galena" or the "Company") (NASDAQ: GALE) and its board of directors concerning whether the board has breached its fiduciary duties to shareholders or violated the federal securities laws.

(Logo: http://photos.prnewswire.com/prnh/20120215/MM54604LOGO )

On February 13, 2014, it was reported that the Company may be compensating and encouraging improper stock promotion.  Company insiders have sold millions of dollars in stock in recent months. 

Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, committed abuses of control, and/or made material misrepresentations in connection with the foregoing.

If you own Galena shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Matthew M. Houston, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400 
                           (212)935-7400
Email:  bsachsmichaels@hfesq.com  
Website:   http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. © 2014 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SOURCE Harwood Feffer LLP